{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:36:46Z","timestamp":1762364206431,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.urolonc.2025.01.017","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T23:34:36Z","timestamp":1739230476000},"page":"335.e1-335.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reducing infectious complications and healthcare costs in transrectal ultrasound-guided prostate biopsy with single-dose cefmetazole and levofloxacin"],"prefix":"10.1016","volume":"43","author":[{"given":"Katsuhiro","family":"Onishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0299-040X","authenticated-orcid":false,"given":"Hiroshi","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tsuchimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshie","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Kamihira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.01.017_bib0001","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complication of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0002","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","article-title":"Complications after prostate biopsy: data from SEER-Medicare","volume":"186","author":"Loeb","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0003","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","article-title":"Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?","volume":"62","author":"Carignan","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0004","unstructured":"Japanese Urological Association (eds). Guidelines for the prevention of perioperative infections in the urological field: 2023 edition. Iga-kutosyo-syuppan, Tokyo, Japan 2023. https:\/\/www.urol.or.jp\/lib\/files\/other\/guideline\/18_ssi_2023.pdf. Last access: 06\/02\/2025."},{"key":"10.1016\/j.urolonc.2025.01.017_bib0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/JU.0000000000000509","article-title":"Best practice statement on urologic procedures and antimicrobial prophylaxis","volume":"203","author":"Lightner","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0006","unstructured":"Bonkat G, Bartoletti R, Bruy\u00e8re F, Cai T, Geerlings SE, K\u00f6ves B, et al. EAU guidelines on urological infections. 2024. https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Urological-Infections-2024.pdf. Last access: 06\/02\/2025."},{"key":"10.1016\/j.urolonc.2025.01.017_bib0007","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/cid\/cit193","article-title":"Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli","volume":"57","author":"Williamson","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0008","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.urology.2014.06.052","article-title":"Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy","volume":"84","author":"Song","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0009","doi-asserted-by":"crossref","first-page":"243","DOI":"10.20411\/pai.v1i2.123","article-title":"Fluoroquinolone-resistant Escherichia coli infections after transrectal biopsy of the prostate in the veterans affairs healthcare system","volume":"1","author":"Saade","year":"2016","journal-title":"Pathog Immun"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jiac.2013.10.003","article-title":"Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) \u2013 a multicenter retrospective study","volume":"20","author":"Togo","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0011","unstructured":"Japanese Nosocomial Infections Surveillance. Annual open report of outpatient data in 2022. Last Access: 06\/02\/2025. https:\/\/janis.mhlw.go.jp\/english\/report\/index.html."},{"issue":"9","key":"10.1016\/j.urolonc.2025.01.017_bib0012","first-page":"1694","article-title":"Concentration of antibiotics in the prostate: cefmetazole","volume":"37","author":"Fujita","year":"1984","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0013","series-title":"The ACCP\/SCCM Consensus Conference Committee","first-page":"1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0014","doi-asserted-by":"crossref","first-page":"E86","DOI":"10.1111\/j.1464-410X.2011.10768.x","article-title":"Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis","volume":"110","author":"Adibi","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0015","article-title":"Variable selection strategies and its importance in clinical prediction modelling","volume":"8","author":"Chowdhury","year":"2020","journal-title":"Fam Med Community Health"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0016","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0017","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jiac.2015.01.014","article-title":"Clinical and microbiological characteristics of spontaneous acute prostatitis and transrectal prostate biopsy-related acute prostatitis: Is transrectal prostate biopsy-related acute prostatitis a distinct acute prostatitis category?","volume":"21","author":"Kim","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0018","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4111\/icu.2016.57.2.94","article-title":"Prevention of sepsis prior to prostate biopsy","volume":"57","author":"Toner","year":"2016","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0019","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.urology.2020.06.005","article-title":"Systematic review and meta-analysis of methods used to reduce infectious complications following transrectal prostate biopsy","volume":"144","author":"Jazayeri","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/antibiotics12010056","article-title":"Ciprofloxacin alone vs. ciprofloxacin plus an aminoglycoside for the prevention of infectious complications following a transrectal ultrasound-guided prostate biopsy: a retrospective cohort study","volume":"12","author":"Thirion","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0021","first-page":"2533","article-title":"A prospective randomized trial comparing a combined regimen of amikacin and levofloxacin to levofloxacin alone as prophylaxis in transrectal prostate needle biopsy","volume":"13","author":"Miyazaki","year":"2016","journal-title":"Urol J"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.684144","article-title":"Monoprophylaxis with cephalosporins for transrectal prostate biopsy after the fluoroquinolone-era: a multi-institutional comparison of severe infectious complications","volume":"11","author":"Wenzel","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0023","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1179\/1973947815Y.0000000059","article-title":"Prophylactic efficacy of cephamycin plus fluoroquinolones in high risk patients on inhibiting infectious complications after transrectal prostate biopsy","volume":"28","author":"Shigemura","year":"2016","journal-title":"J Chemother"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0024","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/uro3020018","article-title":"Targeted antimicrobial prophylaxis with cefmetazole based on presence of fluoroquinolone-resistant isolates to prevent post-prostate biopsy infectious complications","volume":"3","author":"Higashi","year":"2023","journal-title":"Uro"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0025","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/JU.0000000000001399","article-title":"Nonantibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis","volume":"205","author":"Pradere","year":"2021","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.01.017_bib0026","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41391-021-00423-3","article-title":"Comprehensive analysis of complications after transperineal prostate biopsy without antibiotic prophylaxis: results of a multicenter trial with 30 days' follow-up","volume":"25","author":"Kohl","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0027","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00345-024-04941-2","article-title":"Infection risk reduction with povidone-iodine rectal disinfection prior to transrectal prostate biopsy: an updated systematic review and meta-analysis","volume":"42","author":"Tsuboi","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0028","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/iju.13960","article-title":"Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli","volume":"26","author":"Hiyama","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0029","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1464-410X.2012.11637.x","article-title":"Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy","volume":"111","author":"Taylor","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.01.017_bib0030","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1179\/1973947815Y.0000000001","article-title":"The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients","volume":"28","author":"Kandemir","year":"2016","journal-title":"J Chemother"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392500016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392500016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:32:18Z","timestamp":1762363938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814392500016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S107814392500016X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.01.017","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing infectious complications and healthcare costs in transrectal ultrasound-guided prostate biopsy with single-dose cefmetazole and levofloxacin","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}